Literature DB >> 28819327

Inflammatory diseases: An IL-9 solution to inflammation resolution.

Megan Cully.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28819327     DOI： 10.1038/nrd.2017.164

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  1 in total

1.  Resolution of inflammation by interleukin-9-producing type 2 innate lymphoid cells.

Authors:  Simon Rauber; Markus Luber; Stefanie Weber; Lisa Maul; Alina Soare; Thomas Wohlfahrt; Neng-Yu Lin; Katharina Dietel; Aline Bozec; Martin Herrmann; Mark H Kaplan; Benno Weigmann; Mario M Zaiss; Ursula Fearon; Douglas J Veale; Juan D Cañete; Oliver Distler; Felice Rivellese; Costantino Pitzalis; Markus F Neurath; Andrew N J McKenzie; Stefan Wirtz; Georg Schett; Jörg H W Distler; Andreas Ramming
Journal:  Nat Med       Date:  2017-07-17       Impact factor: 53.440
  1 in total
  2 in total

1.  Discoidin Domain Receptor 1 is a therapeutic target for neurodegenerative diseases.

Authors:  Alan J Fowler; Michaeline Hebron; Kaluvu Balaraman; Wangke Shi; Alexander A Missner; Jonathan D Greenzaid; Timothy L Chiu; Clementina Ullman; Ethan Weatherdon; Val Duka; Yasar Torres-Yaghi; Fernando L Pagan; Xiaoguang Liu; Habtom Ressom; Jaeil Ahn; Christian Wolf; Charbel Moussa
Journal:  Hum Mol Genet       Date:  2020-10-10       Impact factor: 6.150

2.  Inhibition of Histone H3K27 Acetylation Orchestrates Interleukin-9-Mediated and Plays an Anti-Inflammatory Role in Cisplatin-Induced Acute Kidney Injury.

Authors:  Wenjuan Jiang; Xinrong Yuan; Hong Zhu; Changsheng He; Caiqiong Ge; Qing Tang; Chuanting Xu; Bingfeng Hu; Cheng Huang; Taotao Ma
Journal:  Front Immunol       Date:  2020-03-03       Impact factor: 7.561
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.